Phibro Animal Health (PAHC) Capital Expenditures (2013 - 2026)

Phibro Animal Health has reported Capital Expenditures for 14 years, with the latest figure at $18.9 million in Q2 2026.

• On a quarterly basis, Capital Expenditures rose 43.58% year-over-year to $18.9 million in Q2 2026; TTM through Jun 2026 was $59.1 million, a 54.3% increase from a year earlier, with the FY2026 full-year figure at $59.1 million, up 54.3% from the prior year.
• Capital Expenditures was $18.9 million for Q2 2026 at Phibro Animal Health, up from $15.3 million in the prior quarter.
• The five-year high for Capital Expenditures was $23.2 million in Q3 2022, with the low at $7.5 million in Q3 2023.
• Average Capital Expenditures over 5 years is $11.8 million, with a median of $10.9 million recorded in 2023.
• The sharpest annual moves came in 2022 and 2023: Capital Expenditures surged 211.13% in 2022, then plunged 67.74% in 2023.
• Over 5 years, Capital Expenditures stood at $9.8 million in 2022, then advanced by 11.61% to $11.0 million in 2023, then dropped by 28.62% to $7.8 million in 2024, then surged by 41.87% to $11.1 million in 2025, then jumped by 70.04% to $18.9 million in 2026.
• The last three Capital Expenditures figures came in at $18.9 million (Q2 2026), $15.3 million (Q1 2026), and $11.1 million (Q4 2025), per Business Quant data.